#ICYMI: Always Look on the Bright Side of (Cell) Death, cytotoxicity assays for antibody drug conjugate development.

Darren Heywood (Promega), Grant Harradence & Robert Francis (Abzena) on ADC potency testing.

Go to https://ow.ly/9TNQ50Ymycj to watch for free

#AntibodyDrugConjugates #Biologics

Daiichi Sankyo gears up for five ADC launches in 2026

#DaiichiSankyo #ADCs #ADClaunches #Enhertu #Datroway #breastcancer #Oncology #antibodydrugconjugates #trastuzumabderuxtecan #datopotamabderuxtecan #pertuzumab #earlystagebreastcancer #triplenegativebreastcancer #Ifinatamabderuxtecan #IDXd #TROPIONBreast05study #ADCtechnology
zurl.co/TySHW

Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment - Nature Reviews Cancer Antibody–drug conjugates are rapidly expanding both in the clinical treatment of cancer and in preclinical development. In this Review, Zippelius et al. highlight the molecular interactions and immune system effects of these sophisticated drugs that drive their efficacy and toxicity.

🥳And coming it at number 1🥁🥁🥁....
Our 1st most downloaded #REVIEW in 2025:

Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment

#ADCs #antibodydrugconjugates @NatResCancer
#NRCtop10of2025

Emma Walmsley upholds £40B sales target in her final GSK CEO report Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. | Emma Walmsley and her ...

#GSK #EmmaWalmsley #LukeMiels #Blenrep #Arexvy #Shingrix #multiplemyeloma #PD1inhibitor #Jemperli #rectalcancer #antibodydrugconjugates #ADCs #HansohPharma #FDAapproval #longactingbiologic #depemokima #chronicrhinosinusitis #biologics #vaccines #shinglesvaccine #RSVvaccine
zurl.co/iumHW

As Blenrep returns, GSK adds another ADC to cancer pipeline GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

#GSK #oncology #Blenrep #ADC #antibodydrugconjugates #prostatecancercandidate #Syndivia #advancedcastrationresistantprostatecancer #CRPC #mCRPC #multiplemyeloma #multiplemyelomaADC #prostatecancer #B7H3targetedADC #Hansoh #osteosarcoma #ESMO #GeminiMabconjugationtechnology
zurl.co/8KpGz

As Blenrep returns, GSK adds another ADC to cancer pipeline GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia.

#GSK has boosted its pipeline of #antibodydrugconjugates for cancer, licensing a #prostatecancer candidate from #Syndivia in a deal that could be worth up to £268 million ($358 million).

pharmaphorum.com/news/blenrep...

👏 Honored for OBI to take part in Biologics World Korea 2025
ADC Bioconjugate East Asia #ADCBio2025 (lnkd.in/e3cExQ-6)
#IMAPAC #BMK2025 #AntibodyDrugConjugates #PrecisionMedicine #LifeSciences

www.obipharma.com/news/biologi...

Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy - PharmaTimes Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in its antibody drug conjugates

#oncology #immunotherapy #AkariTherapeutics #novelPH1payload #targetedcancertherapy #PH1 #antibodydrugconjugates #ADCs #oncogenicmutations #DNAsplicing #neoantigens #missplicedproteins #effluxtransporters #oncogenicdrivers #PH1spliceosomemodulatorpayload
pharmatimes.com/news/akari-t...

Antibody Drug Conjugate Market Size, Trends Report 2035 Antibody Drug Conjugate Market Industry is expected to grow from 9.17(USD Billion) in 2024 to 22.5(USD Billion) by 2035. The Antibody Drug Conjugate Market CAGR (growth rate) is expected to be around ...

🧫🔗 Smart drugs, strong outcomes! ADCs are the future of precision oncology.
#AntibodyDrugConjugates #CancerTreatment #TargetedTherapy #Biopharma 🌍💉

www.marketresearchfuture.com/reports/anti...

Don't miss this recent Current Oncology Reports review on #AntibodyDrugConjugates in #BreastCancer: The Road Towards Biologically-Informed Selection and Sequencing pubmed.ncbi.nlm.nih.gov/39786525/
@ptarantinomd.bsky.social @ilanaschlam.bsky.social @stolaney1.bsky.social #AnaGarridoCastro

Target Specific Cell Based Assays for DACs Explore groundbreaking DACs combining antibodies & PROTACs for precise protein degradation. Revolutionizing therapy for cancer & autoimmune diseases.

Degrader-Antibody Conjugates (DACs) – Transforming Immunotherapy
www.marinbio.com/degrader-ant...
#AntibodyDrugConjugates #ADC #PROTAC #MolecularGlue #TargetedProteinDegraders #TPD #DegraderAntibodyConjugates #DACs
#immunotherapy #cancer

#BGICC2025 #BreastCancer #AntibodyDrugConjugates #HopeRugo #CancerTreatment #OncologyInnovation #Medicine #Health #Oncology #OncoDaily #Cancer #bcsm

#BGICC2025 #BreastCancer #AntibodyDrugConjugates #HopeRugo #CancerTreatment #OncologyInnovation #Medicine #Health #Oncology #OncoDaily #Cancer #bcsm

Check out this new systematic review and meta-analysis discussing #AntibodyDrugConjugates in patients with advanced/metastatic HER2-low-expressing #BreastCancer.
🔓https://pubmed.ncbi.nlm.nih.gov/39574495/
@ptarantinomd.bsky.social

Check out this recent review on the role of #AntibodyDrugConjugates in the treatment of patients with #BreastCancerBrainMetastases.
pubmed.ncbi.nlm.nih.gov/39529890/
#StaceyPan @drsarahsammons.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social @ilanaschlam.bsky.social @ptarantinomd.bsky.social

🚀 Diving into the future of medicine with the booming #AntibodyDrugConjugates (ADC) Market! 💉💊 These innovative therapies are set to revolutionize cancer treatment. Stay ahead of the game! shorturl.at/Uj19d #FutureOfMedicine #HealthRevolution #DrugDevelopment #Oncology #CancerTreatment